RAP 0.00% 20.5¢ resapp health limited

A new Beginning..., page-2388

  1. 26,854 Posts.
    lightbulb Created with Sketch. 1738
    I am not sure if OSA can bring in $20M per year as a diagnosis tool given once you've been diagnosed, you buy the treatment and don't use the diagnosis tool again.....if it brings in at least $5M per year in revenue and with manufacturing cost of virtually zero, the statutory profit will be very good and will mean no CR required.
    Last edited by AlCp: 04/02/19
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.